Who is sponsoring NCT04014140?

NCT04014140 is sponsored by Prakash Punjabi.

What drugs are being tested in NCT04014140?

Interventions in NCT04014140: Coronary artery bypass grafting surgery (CABG).

What condition does NCT04014140 study?

NCT04014140 studies Ischaemic Heart Disease, Coronary Artery Disease, Coronary Stenosis.

Is NCT04014140 still recruiting?

NCT04014140 is currently recruiting now. Last updated 21 November 2023.

Last reviewed 2023-11-21 · How we verify

NCT04014140: iCABG

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

iFR Guided Coronary Artery Bypass Grafting Surgery

Recruiting now Last updated 21 November 2023

What this trial tests

trial testing Coronary artery bypass grafting surgery (CABG) in Ischaemic Heart Disease in 100 participants. Currently enrolling.

Timeline

25 April 2022

Primary endpoint
31 August 2025

31 August 2026

Quick facts

Lead sponsor	Prakash Punjabi
Status	Recruiting now
Study type	OBSERVATIONAL
Enrollment	100
Start date	25 April 2022
Primary completion	31 August 2025
Estimated completion	31 August 2026
Sites	1 location across United Kingdom

Drugs / interventions tested

Coronary artery bypass grafting surgery (CABG)

Conditions studied

Ischaemic Heart Disease — all drugs for Ischaemic Heart Disease →
Coronary Artery Disease — all drugs for Coronary Artery Disease →
Coronary Stenosis — all drugs for Coronary Stenosis →

Sponsor

Prakash Punjabi

Who can join

Adults 25 to 80, any sex, with Ischaemic Heart Disease or Coronary Artery Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The expected outcome of better and improved patency of bypass grafts and its direct relation to pre-operative iFR measurements of stenosis as compared to direct visual physiology of stenosis in the coronary angiogram. To establish the correlation between the use of intracoronary physiology and improved graft patency at 12 months for patients undergoing CABG surgery. It is a minimum of 28 and a maximum of 100 patients single-centre proof or concept/ observational study/ pilot study.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Ischaemic Heart Disease

Currently open trials in the same condition.

NCT07035171 — CABGpreHAB - a Feasibility Study Protocol · NA · recruiting
NCT04674449 — iCorMicA - Stratified Medicine in Angina · NA · recruiting
NCT04193475 — Machine Learning in Quantitative Stress Echocardiography · recruiting
NCT03603210 — Outcomes of Drug Coated Balloon Angioplasty, A UK Real Life Experience From 2009 to 2015 · active not recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04014140 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Prakash Punjabi
Last refreshed: 21 November 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04014140.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing